175 related articles for article (PubMed ID: 16264159)
1. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
Brewster WR; Hubbell FA; Largent J; Ziogas A; Lin F; Howe S; Ganiats TG; Anton-Culver H; Manetta A
JAMA; 2005 Nov; 294(17):2182-7. PubMed ID: 16264159
[TBL] [Abstract][Full Text] [Related]
2. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations.
Cardin VA; Grimes RM; Jiang ZD; Pomeroy N; Harrell L; Cano P
Public Health Rep; 2001; 116(6):608-16. PubMed ID: 12196621
[TBL] [Abstract][Full Text] [Related]
3. Single-visit program for cervical cancer prevention in a high-risk population.
Burger RA; Monk BJ; Van Nostrand KM; Greep N; Anton-Culver H; Manetta A
Obstet Gynecol; 1995 Oct; 86(4 Pt 1):491-8. PubMed ID: 7675367
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
5. Incidence and evaluation of an AGUS Papanicolaou smear in primary care.
Valdini A; Vaccaro C; Pechinsky G; Abernathy V
J Am Board Fam Pract; 2001; 14(3):172-7. PubMed ID: 11355048
[TBL] [Abstract][Full Text] [Related]
6. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
7. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
8. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection.
Ronnett BM; Manos MM; Ransley JE; Fetterman BJ; Kinney WK; Hurley LB; Ngai JS; Kurman RJ; Sherman ME
Hum Pathol; 1999 Jul; 30(7):816-25. PubMed ID: 10414501
[TBL] [Abstract][Full Text] [Related]
9. Abnormal Papanicolaou smears and colposcopic follow-up among American Indian and Alaska Native women in the Pacific northwest.
Gilbert TJ; Sugarman JR; Cobb N
J Am Board Fam Pract; 1995; 8(3):183-8. PubMed ID: 7618496
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: a randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women.
Duggan C; Coronado G; Martinez J; Byrd TL; Carosso E; Lopez C; Benavides M; Thompson B
BMC Cancer; 2012 May; 12():170. PubMed ID: 22559251
[TBL] [Abstract][Full Text] [Related]
11. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
Elit L; Krzyzanowska M; Saskin R; Barbera L; Razzaq A; Lofters A; Yeritsyan N; Bierman A
Can Fam Physician; 2012 Jan; 58(1):e22-31. PubMed ID: 22267636
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
13. The costs of an outreach intervention for low-income women with abnormal Pap smears.
Wagner TH; Engelstad LP; McPhee SJ; Pasick RJ
Prev Chronic Dis; 2007 Jan; 4(1):A11. PubMed ID: 17173719
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995.
Lawson HW; Lee NC; Thames SF; Henson R; Miller DS
Obstet Gynecol; 1998 Nov; 92(5):745-52. PubMed ID: 9794662
[TBL] [Abstract][Full Text] [Related]
15. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
Benard VB; Lee NC; Piper M; Richardson L
Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
[TBL] [Abstract][Full Text] [Related]
16. Detection of human papillomavirus in cervical biopsies of summer camp ROTC cadets with abnormal papanicolaou smears.
Stafford EM; Stewart RS; Teague GR; Gomez RR; Crothers BA; Michel TJ; Patience TH; Moore DC
J Pediatr Adolesc Gynecol; 1996 Aug; 9(3):119-24. PubMed ID: 8795786
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women.
Chhieng DC; Elgert P; Cohen JM; Cangiarella JF
Cancer; 2001 Feb; 93(1):1-7. PubMed ID: 11241259
[TBL] [Abstract][Full Text] [Related]
18. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
19. Efforts to improve the follow-up of patients with abnormal Papanicolaou test results.
Block B; Branham RA
J Am Board Fam Pract; 1998; 11(1):1-11. PubMed ID: 9456441
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
